Peptides against viral and AMR infections
Innovative and disruptive development of bio active peptides
Based on quantum physics, our method is capable of designing bio active peptides with single functionality, peptides are not toxic and cause no side effects.
Technology:
Microorganisms:
Application:
Development stage:
- Infection prevention
- Antimicrobial stewardship
- Microbial diagnostics
- Antimicrobial compound/strategy
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Viruses
- Fungi
- Yeasts
- Parasites
Application:
- Human
- Veterinary
- AgriFood
- Environmental
- Other
Development stage:
- Development
- Validation
- Research
- Market entry
- Marketed product
Organization:
Partnering:
Funding organisation:
Infectious disease area:
Geographic origin:
- Company
- Academia
- Institute
- NGO
- Government
Partnering:
- License
- Co-develop
- Joint Venture
- Outsource
- Sell
Funding organisation:
- OTHER / NA
- CARB-X
- FIND
- GARDP
- REPAIR
Infectious disease area:
- RTI
- UTI
- STI
- BSI
- GII
- SSTI
- CNSI
- IAI
- SSI
Geographic origin:
- Eurasia
- North America
- South America
- Africa
- Oceania
N.A.
QBR is a Danish innovative company successfully developing bio-active peptides against viral and AMR infections using disruptive and innovative RRM model.
Development of bio-active peptides against Bird Fly H5 and Influenza A
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!